Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Cancer
- Women’s longevity.Science. 1995; 270: 719-720
- Acute myocardial infarction: differing preinfarction and clinical features according to infarct site and gender.Int J Cardiol. 2003; 90: 189-196
- Male gender adversely affects survival following surgery for colorectal cancer.Br J Surg. 2003; 90: 711-715
- Gender as a prognostic factor in patients with renal cell carcinoma.BJU Int. 2002; 90: 32-36
- Soft tissue sarcomas in Iceland 1955–1988. Analysis of survival and prognostic factors.Acta Oncol. 1991; 30: 563-568
- The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group.Eur J Cancer. 1998; 34: 2271-2278
- Sex differentials in health.Public Health Rep. 1982; 97: 417-437
Table available from the EUROCARE web-site <http://www.eurocare.it/Document/MorphologyTransCodingTableO2toO3.pdf> accessed 03.04.08].
- The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis.Eur J Cancer. 2009; 45: 909-930
- Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study.The Lancet Oncology. 2007; 8: 773-783
- WHO International classification of diseases for oncology.3rd ed. WHO, Geneva2000
- Canadian Cancer Registries Epidemiology Research Group. Risk factors for male breast cancer in Canada, 1994–1998.Eur J Cancer Prev. 2002; 11: 253-263
- Standard cancer population for estimating age standardising survival ratios.Eur J Cancer. 2004; 40: 2307-2316
- The statistical comparison of relative survival rates.Biometrics. 1983; 39: 941-948
- Cancer survival corrected for heterogeneity in patient withdrawal.Biometrics. 1982; 38: 933-942
- Regression models for relative survival.Statistics in Medicine. 2004; 23: 51-64
Surveillance Research Program, National Cancer Institute SEER∗Stat software <www.seer.cancer.gov/seerstat> version 6.3.6.
StataCorp. Stata statistical software: release 9.0. College Station, TX: Stata Corporation; 2001.
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary.Eur J Cancer. 2009; 45: 931-991
- Relative survival in elderly cancer patients in Europe.Eur J Cancer. 1998; 34: 2264-2270
- Variation in survival of patients with lung in Europe, 1985–1989.Eur J Cancer. 1998; 34: 2191-2196
- Sex differences in lung cancer survival: do tumors behave differently in elderly women?.J Clin Oncol. 2007; 25: 1705-1712
- Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours.Eur J Cancer. 1998; 34: 2154-2161
- Survival of patients with oesophageal and gastric cancers in Europe.Eur J Cancer. 1998; 34: 2167-2175
- Survival of adult patients with cancer of soft tissue or bone in Europe.Eur J Cancer. 1998; 34: 2212-2217
- Survival rates for primary malignant brain tumours in Europe.Eur J Cancer. 1998; 34: 2241-2247
- Variation in survival of adult patients with haematological malignancies in Europe since 1978.Eur J Cancer. 1998; 34: 2253-2263
- Gender and cutaneous melanoma.Br J Dermatology. 1997; 136: 657-665
- The effect of female sex hormones on cancer survival: a register-based study in patients younger than 20 years at diagnosis.JAMA. 1990; : 2189-2193
- Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe.Eur J Cancer. 1998; 34: 2184-2190